ARTICLES
Case Study: Risperidone in Children and Adolescents with Schizophrenia

https://doi.org/10.1097/00004583-199510000-00014Get rights and content

ABSTRACT

Schizophrenia in children is an uncommon disorder with devastating effects. Study of the efficacy of treatment with neuroleptics in children with schizophrenia is only now beginning, and there are limited studies on the effectiveness of novel neuroleptics on the positive and negative symptoms of schizophrenia in children. Four patients with schizophrenia, aged 12 to 17 years, were treated with risperidone (4 to 5 mg/day), a 5-HT2/D2 receptor blocking agent, to determine its effectiveness. Three patients had substantial improvement in their negative symptoms without side effects.

REFERENCES (25)

  • BA Bettes et al.

    Positive and negative symptoms in psychotic and other psychiatrically disturbed children

    J Child Psychol Psychiatry

    (1987)
  • M Campbell et al.

    Neuroleptic induced dyskinesias in children

    Clin Neuropharmacol

    (1983)
  • Cited by (67)

    • Schizophrenia in children and adolescents

      2016, The Medical Basis of Psychiatry: Fourth Edition
    View all citing articles on Scopus

    This study was partially supported by NIMH grant MH 45156. The authors thank Dr. Nina Schooler for her helpful suggestions.

    View full text